GlycoPEGylated recombinant factor IX for hemophilia B in context

about

GlycoPEGylated recombinant factor IX for hemophilia B in context

Item

http://www.wikidata.org/entity/Q57158345

description

im September 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

GlycoPEGylated recombinant factor IX for hemophilia B in context

@en

GlycoPEGylated recombinant factor IX for hemophilia B in context

@nl

type

Item

label

GlycoPEGylated recombinant factor IX for hemophilia B in context

@en

GlycoPEGylated recombinant factor IX for hemophilia B in context

@nl

prefLabel

GlycoPEGylated recombinant factor IX for hemophilia B in context

@en

GlycoPEGylated recombinant factor IX for hemophilia B in context

@nl

P1476

GlycoPEGylated recombinant factor IX for hemophilia B in context

@en

P2093

Elena Santagostino

http://www.w3.org/2001/XMLSchema#string

Maria Elisa Mancuso

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Treatment of hemophilia B: focus on recombinant factor IX.

Recombinant long-acting glycoPEGylated factor IX in hemophilia B: a multinational randomized phase 3 trial

Prophylactic dosing of factor VIII and factor IX from a clinical pharmacokinetic perspective.

Safety of PEGylated recombinant human full-length coagulation factor VIII (BAX 855) in the overall context of PEG and PEG conjugates

PEGylated proteins: evaluation of their safety in the absence of definitive metabolism studies.

Barriers and perceived limitations to early treatment of hemophilia.

Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptide.

The hope and reality of long-acting hemophilia products.

Haemophilia B: current pharmacotherapy and future directions.

Changing paradigm of prophylaxis with longer acting factor concentrates.

P304

2933-2943

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.2147/DDDT.S121743

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2018-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30254423

http://www.w3.org/2001/XMLSchema#string

P921

macromolecular substances

P932

6141116

http://www.w3.org/2001/XMLSchema#string